Abstraction Health

DHEA

Hormone Precursor

Also known as: Dehydroepiandrosterone · DHEAS

🟠Weak Evidence 26 expert mentions 20 studies referenced

A prohormone produced by the adrenal glands that serves as a precursor to both testosterone and estrogen. Levels peak in early adulthood and decline ~2% per year. Studied for aging, libido, adrenal insufficiency, and bone density.

Common forms:oral capsuletopical creamsublingual

How expert claims hold up

13 of 26 claims assessed
13Insufficient13Pending

0 of 13 assessed claims supported or partially supported by published research

Evidence Summary

PubMed / NCBI·May 2026
All 20 studies
20
Studies
2
RCTs
16
Reviews

The available research on DHEA as a supplement covers a broad range of potential applications, including bone health, body composition, hormonal support, and aging-related decline. The body of literature provided spans narrative reviews, one systematic review on a related compound (7-keto-DHEA), and one meta-analysis focused on bone mineral density. However, the majority of sources are review articles with moderate quality ratings, and critically, the structured data fields — including specific populations studied, sample sizes, key findings, and limitations — are absent across all 15 studies. This severely limits the strength of any conclusions that can be drawn from this particular evidence base. The strongest individual study type present is a meta-analysis of randomized placebo-controlled trials examining DHEA's effect on bone mineral density in healthy adults, which represents the most methodologically rigorous evidence available here. A systematic review also examined the related metabolite 7-keto-DHEA and body weight. Several reviews address DHEA in the context of adrenal aging (adrenopause), its pharmacological properties, its role in female androgen physiology, and its use in assisted reproduction (IVF). One review specifically addresses DHEA's relevance in athletic and doping contexts. Despite this breadth of topics covered, because no quantitative findings or population details were extractable from any of the provided articles, all 13 expert claims assessed were rated as having insufficient evidence support. Key limitations of this evidence base are substantial. Most sources are review articles, which synthesize existing data but do not generate new evidence, and their conclusions cannot be verified without access to the underlying data. The absence of extractable findings, sample sizes, and population descriptors means it is impossible to determine whether results apply to specific groups such as older adults, women, athletes, or those with hormonal deficiencies. Furthermore, DHEA functions as a precursor to both testosterone and estrogen, meaning its effects are likely highly context-dependent — varying by sex, age, baseline hormone levels, and dosage — nuances that cannot be assessed from the information available. What remains unknown includes optimal dosing, long-term safety, and which populations, if any, derive meaningful clinical benefit.

Read full evidence summary →

Top studies

A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA supplementation of bone mineral density in healthy adults.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2019 · Lin H et al.
Meta-Analysis🟢
Key finding

A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA supplementation of bone mineral density in healthy adults.

PMID: 31237150DOI: 10.1080/09513590.2019.1616175
View on PubMed

Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials.

Nutrition, metabolism, and cardiovascular diseases : NMCD · 2020 · Qin Y et al.
Meta-Analysis🟢
Key finding

Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials.

COI: Declaration of Competing Interest The authors declare no conflict of interest.
PMID: 32675010DOI: 10.1016/j.numecd.2020.05.015
View on PubMed

Expert Mentions

All 26 mentions
Peter Attia
Early Medical / The Drive Podcast· MD
Caution / warning

"because it's a steroid precursor, there are theoretical concerns about hormone-sensitive cancers."

Extracted claim

Because DHEA is a steroid precursor, there are theoretical concerns about hormone-sensitive cancers.

Insufficient evidence to assessHigh extraction confidence

None of the 10 provided studies directly investigate the relationship between DHEA supplementation and hormone-sensitive cancers (e.g., breast or prostate cancer). The closest relevant study is PMID 36121077, a review on DHEA's pharmacological effects, but no key findings are reported in the provided data. While Attia's concern is biologically plausible given DHEA's role as a steroid precursor that can convert to androgens and estrogens, the available evidence base provided here does not contain studies that either confirm or refute a causal or associative link to hormone-sensitive cancers.

Peter Attia
Early Medical / The Drive Podcast· MD
Caution / warning

"supraphysiological levels can be androgenic."

Extracted claim

Supraphysiological DHEA levels can be androgenic.

Insufficient evidence to assessHigh extraction confidence

While the claim that supraphysiological DHEA levels can be androgenic is biologically plausible given DHEA's known role as a precursor to androgens like testosterone and DHT, none of the provided studies directly address or test this specific claim with extractable key findings. The most relevant studies (PMID 36121077 on DHEA pharmacology, PMID 16888459 on testosterone prohormone supplements, PMID 12943723 on androgens in women, and PMID 14644837 on androgens and antiandrogens) could theoretically contain supporting evidence, but no key findings are reported in the provided data to confirm this. Without extractable findings from these studies, a direct evidence-based comparison cannot be made.

Key findings

  • ·A meta-analysis of randomized placebo-controlled trials examined DHEA's effect on bone mineral density in healthy adults, representing the highest quality evidence in this set — but findings are not extractable from the data provided.
  • ·A systematic review assessed the related compound 7-keto-DHEA for effects on body weight, suggesting some research interest in DHEA metabolites for body composition, though conclusions remain unavailable.
  • ·Multiple review articles suggest DHEA plays a role in age-related hormonal decline (adrenopause), female androgen physiology, and IVF outcomes, but these are narrative overviews without quantifiable evidence summaries.

Evidence gaps

  • ·No extractable data on populations, sample sizes, or specific outcomes was available from any of the 15 studies, making it impossible to determine for whom DHEA supplementation may or may not be effective.
  • ·Long-term safety data, optimal dosing ranges, and the clinical significance of DHEA-driven hormone conversion (to testosterone or estrogen) in healthy versus deficient individuals are not addressed in the available evidence.
  • ·The evidence base relies heavily on review articles rather than primary RCTs, leaving key questions about efficacy for specific outcomes — such as muscle mass, mood, libido, and bone density — without direct, high-quality trial support in this dataset.